Keskinidou Chrysi, Vassiliou Alice Georgia, Papoutsi Elena, Jahaj Edison, Dimopoulou Ioanna, Siempos Ilias, Kotanidou Anastasia
First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 106 76 Athens, Greece.
Biomedicines. 2024 May 13;12(5):1081. doi: 10.3390/biomedicines12051081.
Acute hypoxemic respiratory failure (AHRF) is defined as acute and progressive, and patients are at a greater risk of developing acute respiratory distress syndrome (ARDS). Until now, most studies have focused on prognostic and diagnostic biomarkers in ARDS. Since there is evidence supporting a connection between dysregulated coagulant and fibrinolytic pathways in ARDS progression, it is plausible that this dysregulation also exists in AHRF. The aim of this study was to explore whether levels of soluble endothelial protein C receptor (sEPCR) and plasminogen differentiate patients admitted to the emergency department (ED) with AHRF. sEPCR and plasminogen levels were measured in 130 AHRF patients upon ED presentation by ELISA. Our results demonstrated that patients presenting to the ED with AHRF had elevated levels of sEPCR and plasminogen. It seems that dysregulation of coagulation and fibrinolysis occur in the early stages of respiratory failure requiring hospitalisation. Further research is needed to fully comprehend the contribution of sEPCR and plasminogen in AHRF.
急性低氧性呼吸衰竭(AHRF)被定义为急性且进行性的,患者发生急性呼吸窘迫综合征(ARDS)的风险更高。到目前为止,大多数研究都集中在ARDS的预后和诊断生物标志物上。由于有证据支持凝血和纤维蛋白溶解途径失调与ARDS进展之间存在关联,因此这种失调在AHRF中也存在似乎是合理的。本研究的目的是探讨可溶性内皮蛋白C受体(sEPCR)和纤溶酶原水平是否能区分因AHRF入住急诊科(ED)的患者。通过ELISA在130例AHRF患者急诊就诊时检测sEPCR和纤溶酶原水平。我们的结果表明,因AHRF到急诊科就诊的患者sEPCR和纤溶酶原水平升高。似乎凝血和纤维蛋白溶解失调发生在需要住院治疗的呼吸衰竭早期。需要进一步研究以全面了解sEPCR和纤溶酶原在AHRF中的作用。